Disease: Weaver Johnson syndrome
- Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein
- Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic
- Defining the risk of SARS-CoV-2 variants on immune protection
- Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
- Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
- Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication
- Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity
- International Consensus Statement on Obstructive Sleep Apnea
- Is the timing of fixation associated with fracture-related infection among tibial plateau fracture patients with compartment syndrome? A multicenter retrospective cohort study of 729 patients
- Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
- Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000-2018
- Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
- SARS-CoV-2 Uses Nonstructural Protein 16 to Evade Restriction by IFIT1 and IFIT3
- SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3
- The Human Nose Organoid Respiratory Virus Model: an <em>Ex Vivo</em> Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics
- The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics
- The human nose organoid respiratory virus model: an ex-vivo human challenge model to study RSV and SARS-CoV-2 pathogenesis and evaluate therapeutics